Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AXDXNASDAQ:BNGONASDAQ:RPIDNASDAQ:SEER On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAXDXAccelerate Diagnostics$0.65$0.03▼$2.09$857K0.22511,446 shs53.64 million shsBNGOBionano Genomics$3.20-3.6%$3.83$2.68▼$48.58$11.17M2.27108,359 shs78,517 shsRPIDRapid Micro Biosystems$3.32+6.1%$2.96$0.58▼$4.04$137.19M1.33195,108 shs116,334 shsSEERSeer$2.01+1.5%$2.03$1.56▼$2.63$116.56M1.54328,125 shs336,523 shs10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAXDXAccelerate Diagnostics0.00%0.00%0.00%-96.18%-96.51%BNGOBionano Genomics-3.61%-12.33%-11.60%-1.54%-93.12%RPIDRapid Micro Biosystems+6.07%-6.48%+5.06%+28.19%+331.17%SEERSeer+1.52%-2.90%-3.37%+6.91%+20.36%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAXDXAccelerate Diagnostics0.9421 of 5 stars0.00.00.04.70.02.50.6BNGOBionano Genomics0.9664 of 5 stars3.11.00.00.00.60.00.6RPIDRapid Micro Biosystems1.9402 of 5 stars2.04.00.00.02.62.50.6SEERSeer2.7423 of 5 stars3.03.00.00.02.53.30.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAXDXAccelerate Diagnostics 4.00Strong BuyN/AN/ABNGOBionano Genomics 2.25Hold$7.00118.75% UpsideRPIDRapid Micro Biosystems 4.00Strong Buy$8.00140.96% UpsideSEERSeer 2.00Hold$3.0049.25% UpsideCurrent Analyst Ratings BreakdownLatest SEER, BNGO, RPID, and AXDX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/9/2025BNGOBionano GenomicsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$10.004/2/2025BNGOBionano GenomicsScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSector Perform ➝ Sector Perform$1.00 ➝ $4.00(Data available from 6/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAXDXAccelerate Diagnostics$11.70M0.00N/AN/A($1.37) per share0.00BNGOBionano Genomics$30.78M0.35N/AN/A$18.12 per share0.18RPIDRapid Micro Biosystems$28.05M5.19N/AN/A$1.75 per share1.90SEERSeer$14.17M8.35N/AN/A$5.54 per share0.36Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAXDXAccelerate Diagnostics-$61.62M-$2.34N/AN/AN/A-471.83%N/A-191.66%N/ABNGOBionano Genomics-$112.02M-$138.92N/A∞N/A-294.05%-125.75%-71.96%8/6/2025 (Estimated)RPIDRapid Micro Biosystems-$46.89M-$1.03N/AN/AN/A-151.22%-56.07%-44.11%8/1/2025 (Estimated)SEERSeer-$86.60M-$1.41N/AN/AN/A-560.90%-24.69%-22.13%8/6/2025 (Estimated)Latest SEER, BNGO, RPID, and AXDX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025BNGOBionano Genomics-$3.49-$1.15+$2.34-$1.15$6.25 million$6.46 million5/13/2025Q1 2025SEERSeer-$0.37-$0.34+$0.03-$0.34$3.25 million$4.21 million5/9/2025Q1 2025RPIDRapid Micro Biosystems-$0.27-$0.26+$0.01-$0.26$6.63 million$7.21 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAXDXAccelerate DiagnosticsN/AN/AN/AN/AN/ABNGOBionano GenomicsN/AN/AN/AN/AN/ARPIDRapid Micro BiosystemsN/AN/AN/AN/AN/ASEERSeerN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAXDXAccelerate DiagnosticsN/A1.501.34BNGOBionano Genomics0.071.701.34RPIDRapid Micro BiosystemsN/A4.613.23SEERSeerN/A19.3418.81Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAXDXAccelerate Diagnostics17.14%BNGOBionano Genomics11.35%RPIDRapid Micro Biosystems52.60%SEERSeer75.20%Insider OwnershipCompanyInsider OwnershipAXDXAccelerate Diagnostics43.60%BNGOBionano Genomics0.90%RPIDRapid Micro Biosystems29.96%SEERSeer11.28%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAXDXAccelerate Diagnostics22025.21 million14.13 millionOptionableBNGOBionano Genomics3003.36 million3.33 millionOptionableRPIDRapid Micro Biosystems20043.83 million30.70 millionNot OptionableSEERSeer16058.87 million52.23 millionOptionableSEER, BNGO, RPID, and AXDX HeadlinesRecent News About These CompaniesYalburga seer’s yoga routine benefits devoteesJune 20 at 8:47 PM | timesofindia.indiatimes.comKarnataka seer says free travel scheme raising mutts' visitors food burdenJune 19 at 10:27 AM | msn.comKarnataka Minister Backs Guarantees After Seer’s Remarks, Rules Out Longer Work Hours ClaimJune 19 at 5:27 AM | msn.comAP: Protect Vedas, save ancient tradition and culture: Udupi Sirur Mutt SeerJune 18 at 10:45 PM | uniindia.comBaba Vanga's chilling WW3 predictionJune 18 at 10:45 PM | msn.comBaba Vanga reveals: 4 zodiac signs will become extremely wealthy by the end of 2025June 18 at 5:45 PM | msn.comSiddaramaiah's guarantee schemes a burden on mutts: SeerJune 18 at 12:46 AM | msn.comCRC Outcomes Better When First of Multiple CancersJune 17, 2025 | medscape.comInsider Selling: Seer, Inc. (NASDAQ:SEER) Director Sells 30,253 Shares of StockJune 17, 2025 | insidertrades.comSeer, Inc. (NASDAQ:SEER) Director Dipchand Nishar Sells 30,253 SharesJune 16, 2025 | marketbeat.comWhere To Find The Seer In Tainted Grail: The Fall Of AvalonJune 13, 2025 | msn.comBright The Seer releases prophecy, sends powerful warning message to Tinubu, watch full videoJune 11, 2025 | msn.comRare cancer diagnoses surge dramatically among millennials, Gen XJune 11, 2025 | msn.comThe SEER Group Expands Northwest Presence With Acquisition of Oregon’s Associated Heating & Air ConditioningJune 10, 2025 | joplinglobe.comKalkine : Top NASDAQ Companies by Market Cap Featuring Seer IncJune 10, 2025 | kalkinemedia.comBright The Seer releases prophecy, reveals “anointed person to win 2027 presidential election”, watch full videoJune 10, 2025 | msn.comWhat Makes Seer, Inc. (SEER) a Strong Momentum Stock: Buy Now?June 10, 2025 | zacks.comSeer takes the lead in Miyawaki model forest developmentJune 10, 2025 | timesofindia.indiatimes.comVerydarkman slams Bright the Seer as she prophecies that Wizkid, Tinubu and Wike should see herJune 9, 2025 | msn.comAl Seer Marine's 'Lucky Gas' VLGC sets sailJune 8, 2025 | wam.aeSurgical Outcomes in OAs With Colorectal CancerJune 8, 2025 | physiciansweekly.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSEER, BNGO, RPID, and AXDX Company DescriptionsAccelerate Diagnostics NASDAQ:AXDX$0.04 +0.04 (+∞) As of 05/14/2025 This is a fair market value price provided by Polygon.io. Learn more.Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.Bionano Genomics NASDAQ:BNGO$3.20 -0.12 (-3.61%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$3.29 +0.09 (+2.81%) As of 06/20/2025 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. The company also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.Rapid Micro Biosystems NASDAQ:RPID$3.32 +0.19 (+6.07%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$3.32 0.00 (-0.15%) As of 06/20/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.Seer NASDAQ:SEER$2.01 +0.03 (+1.52%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$2.00 0.00 (-0.25%) As of 06/20/2025 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Overheated Market? Analysts Watch These Red Flags Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
